➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Medtronic
McKesson
Colorcon
Merck

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

Litigation Details for INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION (D.N.J. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION (D.N.J. 2014)

Docket   Start Trial Date Filed 2014-11-07
Court District Court, D. New Jersey Date Terminated
Cause 15:1 Antitrust Litigation Assigned To Madeline Cox Arleo
Jury Demand Plaintiff Referred To Michael A. Hammer
Patents 6,045,501; 6,281,230; 6,315,720; 6,555,554; 6,561,976; 6,561,977; 6,755,784; 7,119,106; 7,465,800; 8,288,415; 8,315,886; 8,404,717
Link to Docket External link to docket
Small Molecule Drugs cited in INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION (D.N.J. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-11-07 1 . Celgene’s patents on the procedures for safe distribution are the 6,045,501 patent, the 6,315,720… Herein 6,045,501501 patent August 28, 1998 April…manufacturer’s patents and patent information for accuracy or trustworthiness. In listing patents and patent information…6,315,720 patent, the 6,561,976 patent, the 6,561,977 patent and the 6,755,784 patent (the “Distribution Method…information describing the patent as a “drug product patent” only if the patent claimed the drug product External link to document
2015-02-03 20 Brief Complaint, IUB only explicitly labels U.S. Patent Nos. 6,045,501, 6,315,720, 6,651,976, 6,561,977, and …three dozen patents, other than the six Distribution Method patents, in its broad patent portfolio covering… Method Patents (Compl. ¶¶ 123-210) – the patent examiner would not have issued the patent claim. See…liable for asserting its patents to preclude generic competition unless the patents in … other patents covering Revlimid and Thalomid were the subject of either fraud on the patent office External link to document
2015-10-29 68 Revlimid: Patent No. 6,045,501 (“the ’501 Patent”); Patent No. 6,315,720 (“the ’720 Patent”); Patent No. …’976 Patent”); Patent No. 6,561,977 (“the ’977 Patent”); Patent No. 6,755,784 (“the ’784 Patent”); and…230 Patent”), Patent No. 6,555,554 (“the ’554 Patent”), Patent No. 7,119,106 (“the ’106 Patent”), and…obtained: the ’720 Patent in 2001; the ’976 Patent and ’977 Patent in 2003; and the ’784 Patent in 2004. (Id…five Distribution Patents, along with Patent No. 5,635,517 (“the ’517 Patent”), Patent No. 6,281,230 ( External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Express Scripts
Baxter
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.